Koshinski Asset Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$313K Sell
7,336
-599
-8% -$32.5K 0.02% 599
2026
Q1
$498K Sell
7,935
-2,162
-21% -$173K 0.03% 434
2025
Q4
$963K Sell
10,097
-3,037
-23% -$298K 0.06% 286
2025
Q3
$1.28M Buy
13,134
+3,878
+42% +$402K 0.09% 225
2025
Q2
$994K Sell
9,256
-3,885
-30% -$393K 0.08% 270
2025
Q1
$1.33M Buy
13,141
+5,665
+76% +$570K 0.11% 189
2024
Q4
$668M Buy
7,476
+50
+0.7% +$4.4K 0.06% 312
2024
Q3
$622K Buy
7,426
+56
+0.8% +$4.41K 0.05% 318
2024
Q2
$564K Buy
7,370
+3,727
+102% +$273K 0.05% 313
2024
Q1
$250K Buy
+3,643
New +$234K 0.03% 474
2022
Q2
Sell
-4,254
Closed -$188K 750
2022
Q1
$188K Buy
4,254
+9
+0.2% +$390 0.02% 603
2021
Q4
$180K Sell
4,245
-1,513
-26% -$63.6K 0.01% 654
2021
Q3
$250K Buy
5,758
+106
+2% +$4.69K 0.02% 547
2021
Q2
$242K Buy
5,652
+50
+0.9% +$2.1K 0.03% 490
2021
Q1
$217K Buy
5,602
+8
+0.1% +$303 0.02% 550
2020
Q4
$201K Sell
5,594
-29
-0.5% -$1.04K 0.03% 515
2020
Q3
$236 Buy
+5,623
New +$217K 0.03% 448
2016
Q1
Sell
-11,367
Closed -$210K 225
2015
Q4
$210K Sell
11,367
-3,952
-26% -$70.8K 0.15% 199
2015
Q3
$271K Sell
15,319
-732
-5% -$12.5K 0.17% 171
2015
Q2
$284K Sell
16,051
-1,062
-6% -$19K 0.18% 164
2015
Q1
$304K Sell
17,113
-950
-5% -$15K 0.2% 157
2014
Q4
$239K Buy
+18,063
New +$231K 0.14% 199

Other funds holding BSX

Koshinski Asset Management's BSX Position: Q2 2026 in Review

Koshinski Asset Management reduced its Boston Scientific (BSX) stake by 7.5% in Q2 2026, selling an estimated $32.5K and leaving 7,336 shares worth $313K. The position accounts for 0.02% of the portfolio, ranked #599.

Koshinski Asset Management first reported a position in BSX in Q4 2014 and has held it in 22 quarters since. The position peaked at $668M in Q4 2024. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Koshinski Asset Management held 7,336 shares of Boston Scientific worth $313K as of Q2 2026.
  • Koshinski Asset Management sold 599 Boston Scientific shares in Q2 2026, an estimated $32.5K.
  • Boston Scientific made up 0.02% of Koshinski Asset Management's portfolio in Q2 2026, its #599 holding.
  • Koshinski Asset Management first reported a position in Boston Scientific in Q4 2014 and has held it in 22 quarters since.
  • Koshinski Asset Management's Boston Scientific position peaked at $668M in Q4 2024.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Koshinski Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.